检验医学 ›› 2012, Vol. 27 ›› Issue (6): 500-502.

• 生物化学检验论著 • 上一篇    下一篇

血清铁、铁蛋白、转铁蛋白、触珠蛋白和α2-巨球蛋白联合检测在肝脏疾病中的应用

原永明   

  1. 1. 上海市徐汇区大华医院检验科,上海 200237;2. 上海市徐汇区大华医院肝科,上海 200237;3. 复旦大学附属中山医院影像诊断科,上海 200032
  • 收稿日期:2012-03-29 修回日期:2012-04-15 出版日期:2012-06-30 发布日期:2012-06-06
  • 作者简介:原永明,男,1963年生,副主任技师,主要从事临床检验及实验室管理工作。
  • 基金资助:

    上海市中医学事业发展首批重大研究项目(ZYSNXD-CC-ZDY)

Application on the combined detection of serum iron,ferritin, transferrin,haptoglobin,alpha 2-macroglobulin in liver diseases

  1. 1. Department of Clinical Laboratory, Shanghai Xuhui District Dahua Hospital,Shanghai 200237,China;2. Department of Liver,Shanghai Xuhui District Dahua Hospital,Shanghai 200237,China;3. Department of Diagnostic Imaging, Zhongshan Hospital,Fudan University,Shanghai 200032,China
  • Received:2012-03-29 Revised:2012-04-15 Online:2012-06-30 Published:2012-06-06

摘要: 目的 探讨血清铁(Fe)、铁蛋白(Ferr)、转铁蛋白(TRF)、触珠蛋白(Hp)、α2-巨球蛋白(α2-MG)与肝脏常见疾病的关系。方法 应用日立7170A全自动生化分析仪分别对98例乙型肝炎患者(慢性肝炎组)、80例肝硬化患者(肝硬化组)及60名正常对照者进行Fe水平的检测;用西门子全自动特定蛋白仪(BNP)对慢性肝炎组、肝硬化组及对照组进行Ferr、TRF、Hp、α2-MG水平的检测。结果  慢性肝炎组:Fe、Ferr水平为(30.40±4.80)μmol/L、(256.00±48.00)μg/L,均明显高于对照组(P<0.05);TRF、Hp水平为(2.18±0.20)g/L、(0.66±0.32)g/L,均明显低于对照组(P<0.05);α2-MG 水平为(2.28±0.39)g/L略高于对照组,但差异无统计学意义(P>0.05)。肝硬化组:Fe、Ferr水平为(33.60±5.00)μmol/L、(287.00±51.00)μg/L,均明显高于对照组(P<0.05);TRF、Hp 水平为(2.00±0.18)g/L、(0.52±0.30)g/L,均明显低于对照组(P<0.05);α2-MG 水平为(2.30±0.40)g/L略高于对照组,但差异无统计学意义(P>0.05)。结论  Fe和Ferr、TRF、Hp、α2-MG可作为肝脏疾病诊断与治疗的重要参考指标,对于判断病情、了解预后有着重要意义。

关键词: 血清铁, 铁蛋白, 转铁蛋白, 触珠蛋白, α2-巨球蛋白, 慢性肝炎, 肝硬化

Abstract: To investigate the relationships of the levels of serum iron(Fe), ferritin(Ferr), transferrin(TRF), haptoglobin(Hp) and alpha2-macroglobulin(α2-MG) with common liver diseases. Methods The Fe levels of 98 hepatitis B patients(chronic hepatitis group), 80 patients with liver cirrhosis (liver cirrhosis group) and 60 healthy subjects (control group) were determined by Hitachi 7170A automatic biochemical analyzer. The serum Fe, TRF, Hp and α2-MG levels in the 3 groups were detected by Siemens automatic specific protein instrument (BNP). Results In chronic hepatitis group, the Fe level (30.40±4.80)μmol/L and Ferr level (256.00±48.00)μg/L were higher than those in the control group (P<0.05). The TRF level (2.18±0.20)g/L and Hp level (0.66±0.32)g/L were significantly lower than those in the control group(P<0.05). The α2-MG level (2.28±0.39) g/L was slightly higher than that in the control group, but without statistical significance (P>0.05). In liver cirrhosis group, the Fe level (33.60±5.00)μmol/L and Ferr level (287.00±51.00)μg/L were higher than those in the control group (P<0.05). The TRF level (2.00±0.18)g/L and Hp level (0.52±0.30)g/L were lower than those in the control group (P<0.05).The α2-MG level (2.30±0.40)g/L was slightly higher than that in the control group, but with no statistical significance (P>0.05). Conclusions Serum Fe,Ferr,TRF,Hp and α2-MG levels can be important indices for predicting the degree of liver diseases, and have significance for disease diagnosis and treatment.

Key words: Serum iron, Ferritin, Transferrin, Haptoglobin, A-macroglobulin, Chronic hepatitis, Liver cirrhosis